Survey Indicator: Majority of Residents Disapprove of Paid COVID-19 Booster Vaccines

The discourse surrounding paid Covid-19 booster vaccines is not supported by the majority of the Indonesian public. This is reflected in the results of a survey conducted by Indikator Politik Indonesia (IPI) and released on Sunday, September 26, 2021. According to the survey, 53.9% of respondents disagreed with having to pay for a Covid-19 booster vaccine.

However, 34.2% of respondents agreed to purchase a booster vaccine, while 12% stated they did not know or did not answer.

The government plans to allow paid booster vaccines for the general public starting in January 2022. The cost is estimated to be between US$7-8 or Rp 100,000 per injection. However, the government will cover the cost of booster vaccines for BPJS Kesehatan participants in the Recipient of Contribution Assistance (PBI) category.

Currently, the government only provides Covid-19 booster vaccines to healthcare workers (HCWs). This aims to provide greater protection for HCWs while performing their duties during the pandemic.

The Indikator survey used online and telephone interviews with 1,200 randomly selected respondents. Respondents were participants who had previously taken part in IPI surveys between March 2018 and June 2021. Furthermore, the sample was randomly selected from all provinces proportionally. The survey's margin of error is 2.9% with a 95% confidence level.